Invokana associated with several life threatening complications include Renal Failure or acute Kidney Failure, Heart Attack, Urinary Tract Infections, Bone Fractures and Ketoacidosis (DKA). On June 14 of 2016, The Food and Drug Administration have issued new safety warnings about the risk of Invokana medication. As per the strengthened warning of the agency Invokana may increase the risk of fatal urinary tract infection and diabetic ketoacidosis which can cause to kidney failure. Based on recent reports, The US Food and Drug Administration (FDA) issued a safety alert which revised the warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk. The FDA has required that manufacturers have to conduct additional post-marketing studies regarding the increased risk of ketoacidosis, kidney failure and other harmful effects associated with the medicine.
Invokana (canagliflozin) is one of several new generation type 2 diabetes drugs known as SGLT2 inhibitors and also available in combination form with the antidiabetic, metformin, sold under the brand name Invokamet. It was approved on March 29, 2013 by U.S Food and Drugs Administration. The drug works by making the kidneys remove sugar from the body through the urine rather than have it be reabsorbed into the blood. Invokana medication uses with diet and exercise to lower blood sugar in adults with type 2 diabetes. It is the product of Janssen Pharmaceuticals, a division of Johnson & Johnson. Pharmaceutical companies have a history of pushing their medications to market without first performing the required testing and research to ensure that the drugs are not linked to serious or life-threatening invokana side effects.
Invokana and Kidney Failure
The FDA approved Invokana in March 2013 and within two years; severe side effects were already being reported to the FDA. In October 2015; FDA received reports of 101 confirmable cases of acute kidney injury, some requiring hospitalization and dialysis, with canagliflozin or dapagliflozin use. More than 100,000 people are affected with Kidney failure in the United States each year. Kidney Failure takes place when the kidneys are no longer able to filter harmful waste and fluids from the bloodstream. This is a serious condition in which the kidneys suddenly stop working, causing dangerous levels of wastes to build up in the body. One may experience swelling, shortness of breath, fatigue, abnormal heart rhythms or even death.
According to the ISMP report, among 457 serious adverse event reports involving Invokana complications were reports of kidney failure, renal impairment, and kidney stones, as well as urinary tract infections, yeast infections and other problems. The study on Invokana reveals that testing and research done both on animals and humans showed signs of risk before the drug were released in the market. Despite the fact that Johnson and Johnson and Janssen were most certainly aware of research which linked these serious health issues with the use of Invokana, the manufacturers fail to adequately research the side effects of this drug and continued to market the drug. The drug maker’s neglected to warn the serious, even deadly risks of the medication to the public.
Plaintiffs from all over the nation filed invokana lawsuits against the manufacturer alleging that there is a link between Invokana and Renal Failure and the manufacturers have failed to warn patients and doctors about the life threatening risk associated with the diabetic medicine. If you or your loved ones experienced Kidney Failure or suffering from any of the symptoms like lower limb amputation, Ketoacidosis (DKA) or other adverse effects while taking Invokana medication, now is the time to seek legal advice. Contact Drugsclaim.com for free evaluation of the case. We have years of experience, knowledgeable and skillful lawyers. All cases are pursued on a contingency fee basis there are never any out-of-pocket costs to hire our attorneys unless we win the case for you.